Hepatotoxicity case due to interferon beta-1a use

Authors : Ramazan Yolaçan, Bekir Kaya, Ümit Karabulut, Ali Üzel, Feyzullah Uçmak, Muhsin Kaya

Pages : 164-167

Doi:10.17941/agd.1333370

View : 29 | Download : 57

Publication Date : 2023-12-22

Article Type : Other Papers

Abstract :Interferon β-1a is an immunomodulatory drug widely used in the treatment of multiple sclerosis. Liver dysfunction is a common side effect of this drug and usually develops within the first 6 months of starting interferon therapy. Here, we present our case who developed hepatotoxicity secondary to interferon β-1a treatment.
Keywords : Multipl skleroz, karaciğer fonksiyon bozukluğu, interferon β